PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinoma
Dillon M. Voss(Cold Spring Harbor Laboratory), Adrian R. Krainer(Cold Spring Harbor Laboratory)
Cited by 6
Related Papers
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth
|Cancer Research|2021|116
Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer
|Cancer Discovery|2023|65
Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression
|Scientific Reports|2017|56
Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy
|Nature Communications|2022|40
Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma
|Science Translational Medicine|2023|28